Global Brand Lead, Epilepsy - Hybrid & High-Impact

UCB

Slough

Hybrid

GBP 120,000 - 180,000

Full time

10 days ago

Get a reply from this employer

Your resume and cover letter, tailored to exactly what they’re hiring for.

Get past ATS filters

Job summary

UCB is seeking a Global Brand Head Epilepsy to lead the epilepsy portfolio worldwide, including BRIVIACT, VIMPAT, KEPPRA and NAYZILAM. You will shape robust commercial and portfolio strategies and partner with stakeholders across markets.

In this role you will drive lifecycle, launches, forecasting, and digital commercialization globally, translating insights into growth while aligning cross-functional teams and ensuring high standards of patient care.

Qualifications

  • Extensive experience in the pharmaceutical, biotechnology, or medical device industry.
  • Several years’ country or regional leadership experience.
  • Strong global marketing, strategic planning, commercialization, and launch experience.
  • Proven cross-functional leadership, influencing, communication, and relationship-building capabilities.
  • Experience developing global strategies, business cases, and complex projects.

Responsibilities

  • Lead global commercial strategies across UCB’s epilepsy brand portfolio.
  • Drive launch, lifecycle, and integrated strategic planning across markets.
  • Translate patient, customer, and market insights into growth opportunities.
  • Align cross-functional stakeholders around portfolio priorities and coordinated execution.
  • Guide forecasting, investment decisions, risk mitigation, and performance optimization.
  • Advance digital, AI-driven, and innovative commercialization approaches globally.

Skills

Pharma/biotech/medical devices
Leadership experience
Global marketing
Strategic planning
Commercialization
Launch experience
Cross-functional leadership
Influencing
Communication
Relationship-building
Global strategies
Business cases
Complex projects

Job description

UCB is seeking a Global Brand Head Epilepsy to lead the epilepsy portfolio worldwide, including BRIVIACT, VIMPAT, KEPPRA and NAYZILAM. You will shape robust commercial and portfolio strategies and partner with stakeholders across markets.

In this role you will drive lifecycle, launches, forecasting, and digital commercialization globally, translating insights into growth while aligning cross-functional teams and ensuring high standards of patient care.

Get your free, confidential resume review.

or drag and drop your file here.

Similar jobs

Similar jobs worth comparing

Global Epilepsy Brand Lead — Hybrid & Launch Expert
Global Epilepsy Brand Lead — Hybrid & Launch Expert

UCB • Reading

Hybrid
GBP 120,000 - 180,000
Global Epilepsy Brand Lead — Strategy & Growth
Global Epilepsy Brand Lead — Strategy & Growth

UCB • City Of London

Hybrid
GBP 120,000 - 160,000
Global Brand Head (m/f/d) Epilepsy (UK)
Global Brand Head (m/f/d) Epilepsy (UK)

UCB • Reading

Hybrid
GBP 120,000 - 180,000
Global Brand Head (m/f/d) Epilepsy (UK)
Global Brand Head (m/f/d) Epilepsy (UK)

UCB • City Of London

Hybrid
GBP 120,000 - 160,000
Global Brand Head (m/f/d) Epilepsy (UK)
Global Brand Head (m/f/d) Epilepsy (UK)

UCB • Slough

Hybrid
GBP 120,000 - 180,000
Regional Market Access Lead for Epilepsy
Regional Market Access Lead for Epilepsy

ACTalent • Taunton

Hybrid
GBP 50,000 - 70,000
Neurology Clinical BD Lead - Partnering & Evaluation
Neurology Clinical BD Lead - Partnering & Evaluation

UCB • Slough

Hybrid
GBP 110,000 - 140,000
Remote Global Medical Director, Epilepsy Pipeline
Remote Global Medical Director, Epilepsy Pipeline

Jazz Pharmaceuticals, Inc. • Greater London

Remote
GBP 180,000 - 240,000
Senior Director, Neuropsychiatry Clinical Development
Senior Director, Neuropsychiatry Clinical Development

Bristol Myers Squibb • Denham

Hybrid
GBP 150,000 - 190,000
Comprehensive benefits
Flexible work options
Inclusion & wellbeing programs
Global Access & Pricing Strategy Lead - Neurology
Global Access & Pricing Strategy Lead - Neurology

UCB • Slough

Hybrid
GBP 90,000 - 130,000